Fasting and Epilepsy: Potential Benefits, Risks, and Clinical Guidance

Fasting (caloric restriction, intermittent fasting, ketogenic diet induction) has complex, bidirectional effects on epilepsy. It is not a standalone treatment and can be dangerous without medical supervision.

Potential Benefits (Primarily via Ketosis)

• Seizure reduction: Ketones (β-hydroxybutyrate, acetoacetate) enhance GABAergic inhibition, reduce glutamate excitotoxicity, modulate K_ATP channels, improve mitochondrial efficiency.
• Ketogenic diet (KD) is the therapeutic application: Structured, sustained ketosis with nutritional adequacy—proven for drug-resistant epilepsy.
• BDNF upregulation: Fasting increases brain-derived neurotrophic factor, supporting neuronal resilience.
• Anti-inflammatory: Reduces neuroinflammation (NLRP3 inflammasome inhibition).

Significant Risks

• Seizure provocation: Hypoglycemia, dehydration, electrolyte shifts (Na⁺, K⁺, Mg²⁺, Ca²⁺), sleep disruption, medication non-adherence (nausea/vomiting).
• Status epilepticus risk: Especially if ASMs missed or levels drop.
• Worsening comorbidities: Diabetes (ketoacidosis/hypoglycemia), cardiac disease, renal impairment, eating disorders, pregnancy.
• Catabolic state: Muscle loss, immunosuppression, hormonal disruption (menstrual irregularity, thyroid).

Clinical Recommendations

1. Never fast for seizure control without neurologist/dietitian approval.
2. If KD indicated: Initiate in specialized center with monitoring (labs, growth, ketones).
3. Religious/voluntary fasting (Ramadan, etc.): Pre-Ramadan counseling—adjust ASM timing, hydration plan, seizure action plan. High-risk patients (uncontrolled, pregnant, comorbid) may be exempt.
4. Intermittent fasting: No epilepsy-specific data; approach cautiously.

Fasting's metabolic effects are real but double-edged. The ketogenic diet harnesses the benefits in a controlled, monitored protocol. Ad hoc fasting is not recommended for epilepsy management.